Reaction
Haemorrhagic Arteriovenous Malformation reporting signals
As of the last recalculation, Haemorrhagic Arteriovenous Malformation appears in 933 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is RIVAROXABAN (PRR 690.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rivaroxaban | 816 | 690.4 | 693.2 |
| Dronedarone | 16 | 35.6 | 35.6 |
| Metolazone | 9 | 18.0 | 18.0 |
| Clopidogrel | 127 | 16.4 | 16.4 |
| Prasugrel Hydrochloride | 4 | 8.8 | 8.8 |
| Dabigatran Etexilate Mesylate | 26 | 8.2 | 8.2 |
| Dabigatran Etexilate | 25 | 7.4 | 7.4 |